<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dietary modification and supplementation play an increasingly important role in the conservative treatment of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Current interest has focused on n-3 polyunsaturated fatty acids (PUFA) and <z:chebi fb="27" ids="27300">vitamin D</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical trial results on this subject are contradictory in many aspects </plain></SENT>
<SENT sid="3" pm="."><plain>Several studies indicate that n-3 PUFA consumption improves vascular and cardiac hemodynamics, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, and possibly endothelial function, autonomic control, <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:mp ids='MP_0005048'>thrombosis</z:mp>, and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Experimental studies show effects on membrane structure and associated functions, ion channel properties, genetic regulation, and production of anti-<z:mp ids='MP_0002501'>inflammatory mediators</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical trials evaluating a possible reduction in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> by n-3 PUFA have shown different results </plain></SENT>
<SENT sid="6" pm="."><plain>Supplementation of <z:chebi fb="27" ids="27300">vitamin D</z:chebi> is common regarding prevention and treatment of <z:hpo ids='HP_0000939'>osteoporosis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>But <z:chebi fb="27" ids="27300">vitamin D</z:chebi> also seems to have several effects on the cardiovascular system </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0100512'>Vitamin D deficiency</z:hpo> appears to be related to an increase in parathyroid hormone levels and can predispose to essential <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo>, increased <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and eventually to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and adverse cardiovascular events </plain></SENT>
<SENT sid="9" pm="."><plain>Randomized prospective clinical trials are needed to determine whether <z:chebi fb="27" ids="27300">vitamin D</z:chebi> and omega-3 FA supplementation therapy should be recommended as a routine therapy for primary or secondary prevention of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
</text></document>